ライフサイエンスコーパス: abdominopelvic

1 Twenty-one men underwent dynamic and static abdominopelvic (18)F FACBC combined positron emission to

2 ients in the experimental arm also underwent abdominopelvic (18)F-fluciclovine PET/CT, and the images

3 nary tract (n = 9), gallbladder (n = 1), and abdominopelvic area (n = 47).

4 Evaluation with a contrast-enhanced abdominopelvic computed tomography (CT) scan demonstrate

5 lymphangioleiomyomatosis underwent chest and abdominopelvic computed tomography (CT).

6 Eighty patients with LAM underwent chest and abdominopelvic CT and abdominopelvic US.

7 n was based on the results from conventional abdominopelvic CT and MRI.

8 y board-certified radiologists at nonfocused abdominopelvic CT and ultimate clinical diagnoses by a c

9 ale patients with blunt trauma who underwent abdominopelvic CT at a level 1 trauma center between Jan

10 ients with HGSOC (median age, 61 years) with abdominopelvic CT before primary cytoreductive surgery a

11 in patients admitted for BAPT who underwent abdominopelvic CT examination (P < .001).

12 unted for anatomic coverage during a typical abdominopelvic CT examination.

13 the pre- and postalgorithm groups: number of abdominopelvic CT examinations at admission, number of a

14 retrospective computerized search of 69,040 abdominopelvic CT examinations performed over a 4-year p

15 The percentage of abdominopelvic CT examinations with BAPT-related finding

16 lvic CT examinations at admission, number of abdominopelvic CT examinations with positive BAPT-relate

17 ally suspected of having acute appendicitis, abdominopelvic CT frequently identifies an alternative c

18 ocial security record who underwent chest or abdominopelvic CT from 2003 to 2007.

19 Chest and abdominopelvic CT images obtained before ASIR implementa

20 Pediatric abdominopelvic CT images with nonvisualized appendix hav

21 Given the prevalent use of abdominopelvic CT in trauma centers, opportunistic scree

22 ing perceived increased cancer risk from one abdominopelvic CT scan.

23 Admission abdominopelvic CT scans from patients 65 years and older

24 In 21 945 patients, 16 851 chest and 24 112 abdominopelvic CT scans were obtained.

25 The following parameters were recorded from abdominopelvic CT study reports for the pre- and postalg

26 patients admitted for BAPT who underwent an abdominopelvic CT study was 76.7% (5900 of 7688) in the

27 The average relative dose reduction for abdominopelvic CT was 29% (4.8/6.8 mGy), with a maximum

28 As a result, an abdominopelvic CT was performed.

29 2 patients were identified who had undergone abdominopelvic CT with a multi-detector row scanner and

30 more than 5 years for patients who underwent abdominopelvic CT within 48 hours of emergent explorator

31 ist 300; Schering, Berlin, Germany) thoracic abdominopelvic CT.

32 for chest CT and 13% (7.8/6.8; P = .40) for abdominopelvic CT.

33 1 291) and 0.1% (six of 11 291, P < .01) for abdominopelvic CT.

34 T and abdominal pain, trauma, and cancer for abdominopelvic CT.

35 maging in a pelvic soft-tissue mass shown on abdominopelvic CT.

36 resections, 22,854 hysterectomies, and 1471 abdominopelvic endovascular procedures.

37 come the routine and preferred procedure for abdominopelvic evaluations with PET imaging.

38 for each patient model for routine chest and abdominopelvic examinations and were normalized by volum

39 From September 1995 to December 2002, 140 abdominopelvic fluid collections were drained at two ins

40 The transgluteal approach to the drainage of abdominopelvic fluid collections with imaging guidance i

41 ues, as well as a variety of extraintestinal abdominopelvic IBD inflammatory bowel disease manifestat

42 Primary abdominopelvic indications were second in frequency to t

43 ies, in clinical practice in a wide range of abdominopelvic indications.

44 tal cancer for survivors treated with direct abdominopelvic irradiation was 1.4% (95% CI, 0.7%-2.6%)

45 ical hyperplasias, primary tumors and paired abdominopelvic metastases to survey the evolutionary lan

46 ower quadrant US and nonenhanced, nonsedated abdominopelvic MR imaging examinations.

47 ally proved acute appendicitis who underwent abdominopelvic multidetector CT.

48 d with the risk of discharge to an ICF after abdominopelvic operations.

49 during a 2-week period with mild to moderate abdominopelvic or flank pain and who underwent CT were s

50 (CTC) is used to examine the colorectum and abdominopelvic organs simultaneously.

51 sions are implicated in the cause of chronic abdominopelvic pain, and many patients are relieved of t

52 adhesions irrespective of reports of chronic abdominopelvic pain.

53 dults aged 65 and older who underwent common abdominopelvic procedures (cholecystectomy, colectomy, h

54 Four of the five abdominopelvic recurrences of disease in the chemotherap

55 ts of CT and arcitumomab were concordant for abdominopelvic resectability, nonresectability, or absen

56 patients undergoing evaluation for curative abdominopelvic resection of colorectal cancer and in the

57 ning, chest radiography, or dedicated CT and abdominopelvic sonography or contrast-enhanced CT.

58 This was an analysis of nonemergent, abdominopelvic surgeries from 2008 to 2014 from a single

59 ost, morbidity, and mortality of unnecessary abdominopelvic surgery and increases those who are poten

60 Opioid use is common before abdominopelvic surgery, and is independently associated

61 Older adults frequently undergo abdominopelvic surgical operations, yet the risk and sig

62 This abdominopelvic survey potential provides radiologists wi

63 omputed tomography (CT) utilization in blunt abdominopelvic trauma (BAPT) over an 8-year period at an

64 In a rabbit abdominopelvic trauma model, dual-contrast DE CT signifi

65 Among survivors, abdominopelvic tumor (adjusted rate ratio [ARR], 3.6; 95

66 ), was compared to that of CT for predicting abdominopelvic tumor resectability by correlating the re

67 urvivor Study (2,002 with and 10,314 without abdominopelvic tumors) and 4,023 sibling participants.

68 (95% CI, 4.4% to 7.3%) among survivors with abdominopelvic tumors, 1.0% (95% CI, 0.7% to 1.4%) among

69 % (95% CI, 0.7% to 1.4%) among those without abdominopelvic tumors, and 0.3% (95% CI, 0.1% to 0.5%) a

70 AM underwent chest and abdominopelvic CT and abdominopelvic US.